ERAS CIK: 1761918

Erasca, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
420
FY22:
444
FY23:
321
FY24:
309
FY25:
286
(positive)
Change from FY21 to FY25
millions USD
FY21:
81.4
FY22:
70.4
FY23:
74.6
FY24:
194
FY25:
110
Total assets
Change from FY21 to FY25
millions USD
FY21:
501
FY22:
515
FY23:
395
FY24:
503
FY25:
396

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
26.2
FY22:
48.7
FY23:
26.2
FY24:
31.4
FY25:
28.5
(negative)
Change from FY21 to FY25
millions USD
FY21:
18.7
FY22:
54.4
FY23:
52.5
FY24:
47.6
FY25:
42.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
457
FY22:
412
FY23:
317
FY24:
423
FY25:
325
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
501
FY22:
515
FY23:
395
FY24:
503
FY25:
396

All amounts in millions USD Data source:SEC EDGAR